Kuros Biosciences AG (SWX:KURN)
Switzerland · Delayed Price · Currency is CHF 25.26
-0.68 (-2.62%)
Mar 13, 2026, 4:15 PM CET
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of 1.02 billion as of March 13, 2026. Its market cap has increased by 20.37% in one year.
Market Cap
1.02B
Enterprise Value
999.56M
Revenue
103.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
25.26
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.25B to 1.02B, a decrease of -68.73%. That is a compound annual growth rate of -10.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 12, 2026 | 1.02B | -5.55% |
| Dec 30, 2025 | 1.08B | 33.56% |
| Dec 30, 2024 | 805.64M | 527.99% |
| Dec 29, 2023 | 128.29M | 138.81% |
| Dec 30, 2022 | 53.72M | -14.90% |
| Dec 30, 2021 | 63.13M | -4.70% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.71B |
| Novartis AG | 232.79B |
| Galderma Group AG | 35.42B |
| Lonza Group AG | 34.38B |
| Cosmo Pharmaceuticals | 1.60B |
| Tecan Group AG | 1.60B |
| Aevis Victoria | 1.16B |
| SKAN Group AG | 1.12B |